Advertisement
U.S. Markets open in 5 hrs 56 mins

Dermata Therapeutics, Inc. (DRMA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.3500+0.0900 (+7.14%)
At close: 04:00PM EST
1.3400 -0.01 (-0.74%)
After hours: 05:25PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.2600
Open1.3000
Bid1.3300 x 100
Ask1.4100 x 100
Day's Range1.2900 - 1.4199
52 Week Range1.2000 - 14.6250
Volume87,079
Avg. Volume545,615
Market Cap2.039M
Beta (5Y Monthly)0.79
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • InvestorPlace

    7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024

    What do you call a growth stock that isn’t growing any more? The answers are many. You can call it a disappointment. A drain on your portfolio. A bad investment. Any of these are true of F-rated growth stocks, as evaluated by the Portfolio Grader. And in today’s market, you can ill-afford to a bad investment. The market is in some turmoil this summer.InvestorPlace - Stock Market News, Stock Advice & Trading Tips I know it’s only temporary, but times like these are when some investors start to pa

  • Zacks

    Dermata (DRMA) Up on FDA Nod to Begin Pivotal Study of Acne Drug

    Dermata (DRMA) announces reaching an agreement with the FDA to begin a late-stage pivotal clinical program for its acne treatment candidate, DMT310. The stock rises 7%.